Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation
- PMID: 17485593
- DOI: 10.1161/CIRCULATIONAHA.106.658237
Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation
Abstract
Background: Stent thrombosis may occur late after drug-eluting stent (DES) implantation, and its cause remains unknown. The present study investigated differences of the stented segment between patients with and without very late stent thrombosis with the use of intravascular ultrasound.
Methods and results: Since January 2004, patients presenting with very late stent thrombosis (> 1 year) after DES implantation underwent intravascular ultrasound. Findings in patients with very late stent thrombosis were compared with intravascular ultrasound routinely obtained 8 months after DES implantation in 144 control patients, who did not experience stent thrombosis for > or = 2 years. Very late stent thrombosis was encountered in 13 patients at a mean of 630+/-166 days after DES implantation. Compared with DES controls, patients with very late stent thrombosis had longer lesions (23.9+/-16.0 versus 13.3+/-7.9 mm; P<0.001) and stents (34.6+/-22.4 versus 18.6+/-9.5 mm; P<0.001), more stents per lesion (1.6+/-0.9 versus 1.1+/-0.4; P<0.001), and stent overlap (39% versus 8%; P<0.001). Vessel cross-sectional area was similar for the reference segment (cross-sectional area of the external elastic membrane: 18.9+/-6.9 versus 20.4+/-7.2 mm2; P=0.46) but significantly larger for the in-stent segment (28.6+/-11.9 versus 20.1+/-6.7 mm2; P=0.03) in very late stent thrombosis patients compared with DES controls. Incomplete stent apposition was more frequent (77% versus 12%; P<0.001) and maximal incomplete stent apposition area was larger (8.3+/-7.5 versus 4.0+/-3.8 mm2; P=0.03) in patients with very late stent thrombosis compared with controls.
Conclusions: Incomplete stent apposition is highly prevalent in patients with very late stent thrombosis after DES implantation, suggesting a role in the pathogenesis of this adverse event.
Comment in
-
What to do about late incomplete stent apposition?Circulation. 2007 May 8;115(18):2379-81. doi: 10.1161/CIRCULATIONAHA.107.697136. Circulation. 2007. PMID: 17485592 No abstract available.
Similar articles
-
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.Circulation. 2009 Aug 4;120(5):391-9. doi: 10.1161/CIRCULATIONAHA.109.854398. Epub 2009 Jul 20. Circulation. 2009. PMID: 19620501
-
What to do about late incomplete stent apposition?Circulation. 2007 May 8;115(18):2379-81. doi: 10.1161/CIRCULATIONAHA.107.697136. Circulation. 2007. PMID: 17485592 No abstract available.
-
Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.Am Heart J. 2005 Aug;150(2):351-7. doi: 10.1016/j.ahj.2004.09.041. Am Heart J. 2005. PMID: 16086942 Clinical Trial.
-
Very late thrombosis after drug-eluting stents.Catheter Cardiovasc Interv. 2006 Jul;68(1):83-8. doi: 10.1002/ccd.20692. Catheter Cardiovasc Interv. 2006. PMID: 16763989 Review.
-
Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound.Am J Cardiol. 2007 Oct 22;100(8B):26M-35M. doi: 10.1016/j.amjcard.2007.08.019. Am J Cardiol. 2007. PMID: 17950829 Review.
Cited by
-
Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions.Cardiol Res. 2024 Jun;15(3):169-178. doi: 10.14740/cr1626. Epub 2024 Jun 25. Cardiol Res. 2024. PMID: 38994223 Free PMC article.
-
Machine Learning-Based Prediction of In-Stent Restenosis Risk Using Systemic Inflammation Aggregation Index Following Coronary Stent Placement.Risk Manag Healthc Policy. 2024 Jul 5;17:1779-1786. doi: 10.2147/RMHP.S468235. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 38989249 Free PMC article.
-
Nanogold-coated stent facilitated non-invasive photothermal ablation of stent thrombosis and restoration of blood flow.Nanoscale Adv. 2024 Jan 30;6(5):1497-1506. doi: 10.1039/d3na00751k. eCollection 2024 Feb 27. Nanoscale Adv. 2024. PMID: 38419863 Free PMC article.
-
Intravascular Imaging Findings After PCI in Patients With Focal and Diffuse Coronary Artery Disease.J Am Heart Assoc. 2024 Mar 5;13(5):e032605. doi: 10.1161/JAHA.123.032605. Epub 2024 Feb 23. J Am Heart Assoc. 2024. PMID: 38390822 Free PMC article.
-
Gallic Acid Inhibits Proliferation and Migration of Smooth Muscle Cells in a Pig In-Stent Restenosis Model.Chonnam Med J. 2024 Jan;60(1):32-39. doi: 10.4068/cmj.2024.60.1.32. Epub 2024 Jan 25. Chonnam Med J. 2024. PMID: 38304132 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
